President Abdel Fatah al-Sisi announced at the first edition of Africa Health ExCon that Egypt would supply fellow African states with 30 million doses of anti-COVID-19 vaccines.
That is in light of the country's selection early in 2022 as one of six African states that would receive the mRNA technology used in the manufacturing of vaccines and other medical drugs necessary to confront many incurable diseases. The other five are Senegal, Kenya, South Africa, Tunisia and Nigeria.
President Sisi vowed to continue sharing know-how and experience with fellow African states in all sectors, and addressed foreign investors saying that the “capabilities of Africa are enormous.”
The chief of state stressed that the focus must not just be on natural resources but that it has to include human capabilities, which are significant on the continent.
The Egyptian president thanked pharmaceuticals companies for cooperating with Egypt in dealing with many diseases. He equally encouraged them to invest in Africa as its population is mostly young and is nearing 1.5 billion, which makes it the future.
"All the companies you see operating in Egypt chose to invest in the country because of safety. They knew that their investments would not be subject to vandalism or destruction," President Sisi underscored, warning against the economic harm incurred by instability and security issues.
Source: Egypt Today
